Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
March 12, 2020 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
May 11, 2020 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
May 12, 2020 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
April 7, 2022 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
April 7, 2022 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
October 30, 2018 424B3

Form of prospectus reflecting facts events constituting substantive change from last form

View HTML
March 17, 2014 FWP

FWP

View HTML
January 7, 2016 FWP

FWP

View HTML
January 18, 2024 3

Initial filing by director officer or owner of more than ten percent

View HTML
January 18, 2024 3

Initial filing by director officer or owner of more than ten percent

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us